8-[3H]-hydroxy-2-(di-n-propylamino)tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization

Journal of Neuroimmunology

Volumn 138, Issue 1-2, 2003, Pages 8-16

  Sempere, Telésfora ^a   Cedeño, Nemesio ^a   Urbina, Mary ^a   Lima, Lucimey ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

5 HT1A receptors; Concanavilin A; Immobilization stress; Lipopolysacharide; Lymphocytes; Serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BUSPIRONE; CONCANAVALIN A; DESIPRAMINE; HALOPERIDOL; IMIPRAMINE; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; NOMIFENSINE; PIMOZIDE; PINDOBIND; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST; SULPIRIDE; UNCLASSIFIED DRUG; SEROTONIN 1 RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CALCULATION; DILUTION; DISSOCIATION CONSTANT; DRUG BINDING; DRUG POTENCY; DRUG SELECTIVITY; IMMOBILIZATION STRESS; IMMUNOMODULATION; KINETICS; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; ANIMAL; BINDING COMPETITION; BLOOD; CELL MEMBRANE; DRUG EFFECT; IMMOBILIZATION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RADIOASSAY; SPRAGUE DAWLEY RAT; STRESS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BUSPIRONE; CELL MEMBRANE; CONCANAVALIN A; IMMOBILIZATION; KINETICS; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MALE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; STRESS;

EID: 0037960382     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00091-2     Document Type: Article

References (73)

1. 1A binding site in rat striatum. J. Pharmacol. 40:1988;888-891.
2. Ameisen J., Robin M., Askenase P. Serotonin-2 receptor antagonist inhibit contact sensitivity by an effect on T cells. J. Immunol. 142:1989;3171-3179.
3. 2 antagonists after intrastriatal injections in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 330:1985;97-125.
4. Aune T., Kelley K.A., Ranges G.E., Bombara M. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J. Immunol. 145:1990;1826-1831.
5. 1A expresion receptors on activated human T cell. J. Immunol. 151:1993;1175-1183.
6. Aune T., Golden H., McGath M. Inhibitors of serotonin synthesis and antagonists of seronin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J. Immunol. 153:1994;489-498.
7. Barlow R.B. Biodata Handling with Microcomputers. 1983;125-143 Elsevier, Amsterdam.
8. Blier P., Montigny C. Serotonergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience. 16:1985;949-955.
9. Blier P., de Montigny C. Modification of 5-HT neuron properties by sustained administration of the 5-HT agonist gempirone electrophysiological studies in the rat brain. Synapse. 1:1987;470-480.
10. Boerner P., Saier M.H. Jr. Adaptive regulatory control of System A transport activity in a kidney epithelial cell line (MDCK) and in a transformed variant (MDCK-T1). J. Cell Physiol. 122(2):1985;308-315.
11. Bonnet M., Lespinats G., Burtin C. Evidence for serotonin binding sites on murine lymphocytes. Int. J. Immunopharmacol. 9:1987;551-558.
12. Borne R.F. Serotonin: the neurotransmetter for '90s. Drugs Topics. 10:1994;108-115.
13. Cao Q., Batey R., Pang G., Russel A., Claney R. IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administred concanvalin A. Immunol. Cell. Biol. 76:1998;542-549.
14. 1A receptor mRNA expression. J. Neurosci. 13:1993;914-923.
15. Connor T., McNamara C.M., Finn D. Acute 3,4-methyelenedioximethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in rat. Immunopharmacology. 38:1998;253-260.
16. 3H-haloperidol. Life Sci. 17:1975;933-1001.
17. Erb C., Klein A., Loffelholz K., Jeltsch H., Cassel J. Modulation of hippocampal acetylcholine release after fimbria-fornix lesions and septal transplantation in rats. Neurosci. Lett. 231:1997;5-8.
18. Farisse J., Hery F., Barden N., Hery M., Boulenguez P. Central 5-HT(1) and 5-HT(2) binding sites in transgenic mice with reduced glucocorticoid receptor number. Brain Res. 862:2000;145-153.
19. 1A receptor. Nature. 335:1988;358-360.
20. Ferriere F., Khan N., Meynel J., Dechaux P. 5-Hydroxytryptamine-induced calcium-channel gating in rainbow trout (Oncorhynchus mykiss) peripheral blood lymphocytes. Biochem. J. 323:1997;251-258.
21. Ferriere F., Khan N.A., Meyniel J.P., Deschaux P. Characterization of serotonin transport mechanisms in rainbow trout peripheral blood lymphocytes: role in PHA-induced lymphoproliferation. Dev. Comp. Immunol. 23(1):1999;37-50.
22. Fielding S., Szewczak M.R. Pharmacology of nomifensine: a review of animal studies. J. Clin. Psychiatry. 45(4 Pt 2):1984;12-20.
23. Fiorucci S., Santucci L., Antonelli E., Distritti E., Del Sero G., Morelli O., Federicie B., Del Soldato P., Morelli A. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent procesing of Th1-like cytokines. Gastroenterology. 118:2000;404-421.
24. Gandolfi R., Barbacci M.L., Costa E. Comparison of iprindole, imipramine and mianserin action on brain serotonergic and β-adrenergic receptors. J. Pharmacol. Exp. Ther. 229:1984;782-786.
25. Glennon R.A., Titeler M., Lyon R.A., Slusher R.M. N,N-di-propylserotonin: binding aat serotonin binding sites and a comparison with 8-hidroxy-2-(di-n-prpylamino)tetralin. J. Med. Chem. 31:1988;867-870.
26. 3H-PAT. Nature. 305:1983;140-142.
27. 1A receptors in rat brain membranes. Eur. J. Pharmacol. 288:1995;173-186.
28. Hamon M., Emerit M.B., El Mestikawy S., Gallissot M.S., Gozlan H. Regional differences in the transduction mechanism of 5-hydroxytryptamine receptors in the mammalian brain. Saxena P.R., Wallis D.I., Wouters W., Bevan P. Cardiovascular pharmacology of 5-hydroxytryptamine. 1989;42-49 Kluwer Academic Publishing, Dordrecht.
29. 1A receptor. Ann. N. Y. Acad. Sci. 600:1990;251-260.
30. Herman J.P., Dolgas C.M., Carlson S.L. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors. Neuroscience. 85:1998;449-459.
31. Heyes M.P., Queary B.J., Markey S.P. Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res. 491:1989;173-179.
32. A1/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiamatic nuclei. J. Neurosci. 20:2000;5867-5873.
33. 3H]8-OH-DPAT labels the 5-HT transporter in human platelets. Life Sci. 42:1988;311-320.
34. 1A receptors. Cell. Immunol. 163:1995;1-9.
35. Jones T.H. Interleukine-6 an endocrine cytokine. Clin. Endocrinol. 40:1994;703-713.
36. Julius D. Serotonin receptor knockouts: a moody subject. Proc. Natl. Acad. Sci. U. S. A. 95:1998;1533-1554.
37. 1A receptors in human leukemia (K 562) cells. Cell. Immunol. 165:1995;148-152.
38. + inflsux in human T cells: role in T cell activation. J. Neuroimmunol. 99:1999;53-60.
39. 1A receptor agonist 8-OH-DPAT is partly responsible for pituitary activation. Eur. J. Pharmacol. 309:1996;281-286.
40. Kow L.M., Tsai Y.F., Wang D.W. Electrophysioligycal analysis of serotonergic actions on neurons in hypothalamic ventromedial nucleus in vitro: receptor subtypes involved and implications for regulations of feeding and lordosis behaviors. Chin. J. Physiol. 35:1992;105-121.
41. Kut J., Young R., Crayton J., Wright M., Young M. Regulation of murine T-lymohocyte function by spleen cell derived and exogenus serotonin. Immunopharmacol. Immunotoxicol. 14:1992;783-796.
42. Kvetnansnky R., Pacak K., Fukuhara K., Viskupic E., Hiremagalur B., Nankova B., Goldstein D.S., Sabban E.L., Kopin I.J. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann. N. Y. Acad. Sci. 77:1995;131-158.
43. a receptor antagonist. Pharmacol. Biochem. Behav. 38:1991;555-559.
44. 1A receptors in e hippocampus and the raphe area of rats treated with clonazepam. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 17:1993;663-677.
45. 3H]Hydroxy-2-(di-n-propylamino) tetralin bindin sites in goldfish retina. Neurochem. Res. 19:1994;249-255.
46. 1A receptors with positron emmission tomography. Life Sci. 55:1994;PL403-PL407.
47. McPherson G.A. Analysis of radioligand binding esperiments: a collection of computer programs for the IBM PC. J. Pharmacol. Methods. 14:1985;213-228.
48. a agonists. Mol. Pharmacol. 37:1990;231-238.
49. Morrison D.C. Endotoxins and disease mechanims. Annu. Rev. Med. 38:1987;417-421.
50. Munson P.J., Rodard D. LIGAND: a versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107:1980;220-239.
51. 3H]Spiroxatrine label a serotonin1A-like site in the rat hippocampus. Life Sci. 41:1987;1567-1576.
52. 3H]hydroxydipropylaminotetralin.
53. Nicoletti F., Beltrami B., Rashi E., DiMarco R., Magro G., Grasso S., Bendtzan K. Protection from concanvalin A induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate. Clin. Exp. Immunol. 110:1997;479-484.
54. 4 receptor agonist on slow synaptic potentials in mienteric neurons. Eur. J. Pharmacol. 278:1995;67-74.
55. Plata-Salamán C.R. Immuregulators in the nervous system I: expression and recognition. T.I.N.S. 18:1991;83-88.
56. 1A receptors on dorsal raphe neurons of the adult rat. J. Physiol. 508:1993;119-129.
57. Raap D.K., DonCarlos L., Garcia F., Muma N.A., Wolf W.A., Battaglia G., Van de Kar L.D. Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus. Neuropharmacology. 39:2000;1823-1832.
58. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J. Jr., Shen Y., Meltzer H.Y., Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268:1994;1403-1410.
59. Santucci L., Fiorucci S., Cammilleri F., Servillo G., Federici B., Morelli A. Galectic-1 exerts immunomodulatory and protective effects on concanvalin A-induced hepatitis in mice. Hepatology. 31:2000;399-406.
60. 1A binding sites directly labeled by [3H]-8-hyddroxy-2-(Di-n-propylamino9tetralin. Biochem. Pharmacol. 35:1986;1943-1949.
61. 1A receptor antagonist. Eur. J. Pharmacol. 1244:1993;251-257.
62. Sokal, R., Rohlf, F., 1979. Biometría. In: Blume, H. (Ed.), Madrid.
63. Song C., Early B., Leonard B.E. Behavioral, neurochemical and immunological responses to CRF administration. Ann. N. Y. Acad. Sci. 771:1995;55-72.
64. 1A selective agonists. Eur. J. Pharmacol. 128:1986;295-298.
65. Sternberg E., Wendner J., Leung M., Parker C. Effect of serotonin and other monoamines on murine macrophages: modulation of interferon-gamma induced phagocytosis. J. Immunol. 138:1987;4360-4365.
66. 1A receptor mediated response by fluoxetine in rat brain. J. Neural Transm. 107:2000;377-387.
67. Terrazino S., Bauleo A., Baldan A., Leon A. Peripheral LPS administrations up-regulate Fas and FasL on brain microglial cells: a brain protective or pathogenic event? J. Neuroimmunol. 124:2002;45-53.
68. Tork I. Anatomy of the serotonergic system. Ann. N. Y. Acad. Sci. 600:1990;9-34.
69. 7 receptor. Eur. J. Pharmacol. 396:2000;1-8.
70. 2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol. Biochem. Behav. 32:1989;691-697.
71. 2 receptors and the serotonin transport site in rat brain. J. Psychiatr. Res. 33:1999;17-22.
72. Young M.R.I., Kut J.L., Coogan M.P., Wright M.A., Young M.E., Matthews J.M. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology. 80:1993;395-400.
73. 3H]5-HT binding sites and 5-HT induced adenylate cyclase activations in rat brain cortex. Brain Res. 44:1988;133-140.